OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	57
Unusual Forms of Pulmonary Hypertension	36
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	31
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	27
Changing Landscape of Heart Failure Imaging	26
Contents	26
Forthcoming Issues	23
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	22
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	21
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	20
When all Else Fails, Try This	20
Preload Reduction Therapies in Heart Failure	19
Therapy-Related Clonal Hematopoiesis	19
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Genetics of High-Altitude Pulmonary Edema	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Contributors	16
Contributors	16
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	15
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	14
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	13
Copyright	13
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	12

Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
Heart Failure Clinics	12
Myocardial Dysfunction in Patients with Cancer	12
Coronary Angiography in the Evaluation of Systolic Heart Failure	11
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	11
Arrythmia-Mediated Valvular Heart Disease	11
Advanced Heart Failure in a Special Population	11
What Is New in Risk Assessment in Nuclear Cardiology?	11
Cardiac Amyloidosis	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	10
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	10
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	10
Contributors	10
Application of 3D Printing Technology in Heart Failure	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	9
Noncoding RNAs in Pulmonary Arterial Hypertension	9
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Contents	9
Cardiac Contractility Modulation	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	9
SGLT2 Inhibitors in Heart Failure	9
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	8
Contents	8
Disease-modifier Drugs in Patients with Advanced Heart Failure	8
Contributors	8
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	7
Copyright	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Preface	7
Inotropes in Patients with Advanced Heart Failure	7
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	6
Aortic Valvular Stenosis and Heart Failure	6
Copyright	6
Advanced Heart Failure in Special Population	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Contents	6
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Adults with Congenital Heart Disease and Transplant	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Remote Monitoring Devices and Heart Failure	5
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	5
The Risk of Sudden Unexpected Cardiac Death in Children	4
Risk Factors for Progression in Hypertrophic Cardiomyopathy	4
Contributors	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4

Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	4
Contents	4
Novel Non-pharmacological Approaches to Heart Failure	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Pathophysiology of Cardiac Amyloidosis	4
Clinical Practice Guidelines in Cardio-Oncology	4